Gyre Therapeutics (GYRE) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -251.08% |
| Dec 31, 2025 | 83.61% |
| Sep 30, 2025 | -169.76% |
| Jun 30, 2025 | -151.44% |
| Mar 31, 2025 | 111.06% |
| Dec 31, 2024 | -18.05% |
| Sep 30, 2024 | 29.56% |
| Jun 30, 2024 | -50.18% |
| Mar 31, 2024 | 524.62% |
| Dec 31, 2023 | -69.64% |
| Sep 30, 2023 | 80.92% |
| Jun 30, 2023 | 8.85% |
| Mar 31, 2023 | -379.85% |
| Dec 31, 2022 | 119.57% |
| Sep 30, 2022 | 69.36% |
| Jun 30, 2022 | -116.54% |
| Mar 31, 2022 | 25.69% |
| Dec 31, 2021 | 27.39% |
| Sep 30, 2021 | 25.42% |
| Jun 30, 2021 | 33.93% |
| Mar 31, 2021 | -0.05% |
| Dec 31, 2020 | -27.22% |
| Sep 30, 2020 | 12.34% |
| Jun 30, 2020 | -12.28% |
| Mar 31, 2020 | 24.45% |
| Dec 31, 2019 | 5.83% |
| Sep 30, 2019 | -56.42% |
| Jun 30, 2019 | -274.63% |
| Mar 31, 2019 | 78.95% |
| Dec 31, 2018 | -230.40% |
| Sep 30, 2018 | 22.82% |
| Jun 30, 2018 | 63.14% |
| Mar 31, 2018 | -194.91% |
| Dec 31, 2017 | -157.31% |
| Sep 30, 2017 | 56.49% |
| Jun 30, 2017 | -40.13% |
| Mar 31, 2017 | 7.87% |
| Dec 31, 2016 | -52.28% |
| Sep 30, 2016 | 18.48% |
| Jun 30, 2016 | 13.43% |
| Mar 31, 2016 | 14.87% |
| Dec 31, 2015 | 11.60% |
| Sep 30, 2015 | -53.93% |
| Jun 30, 2015 | 29.17% |
| Mar 31, 2015 | -1,750.44% |
| Dec 31, 2014 | 96.74% |
| Sep 30, 2014 | 42.88% |
| Jun 30, 2014 | -0.48% |
| Mar 31, 2014 | -139.10% |
| Dec 31, 2013 | 57.96% |
| Sep 30, 2013 | 3.43% |
| Jun 30, 2013 | 8.78% |
| Mar 31, 2013 | -138.15% |
| Dec 31, 2012 | 67.90% |
| Sep 30, 2012 | 8.17% |
| Jun 30, 2012 | 11.37% |
| Mar 31, 2012 | 9.46% |
| Dec 31, 2011 | 8.65% |
| Sep 30, 2011 | 8.45% |
| Jun 30, 2011 | -67.95% |
| Mar 31, 2011 | 35.13% |
| Dec 31, 2010 | -15.19% |
| Sep 30, 2010 | 16.17% |